Does BENDAMUSTINE Cause Squamous cell carcinoma? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Squamous cell carcinoma have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 0.4% of all adverse event reports for BENDAMUSTINE.
70
Reports of Squamous cell carcinoma with BENDAMUSTINE
0.4%
of all BENDAMUSTINE reports
10
Deaths
21
Hospitalizations
How Dangerous Is Squamous cell carcinoma From BENDAMUSTINE?
Of the 70 reports, 10 (14.3%) resulted in death, 21 (30.0%) required hospitalization, and 3 (4.3%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENDAMUSTINE. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which BENDAMUSTINE Alternatives Have Lower Squamous cell carcinoma Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE